An Exploratory, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Describe the Virological Effect, Safety, and Pharmacokinetics of a Single Intravenous (IV) Dose of VIR-7831 Monoclonal Antibody in Hospitalized Participants With Coronavirus Disease 2019 (COVID-19)
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms COMET-ACE
- Sponsors GlaxoSmithKline; GSK
- 02 Mar 2021 New trial record